Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma

ClinicalTrials.gov ID: NCT04919122

Public ClinicalTrials.gov record NCT04919122. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma (ODYSSEY RCC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

ODYSSEY RCC is a prospective, observational Phase IV study is to understand the cancer management and health-related quality of life in patients with mRCC in routine real-world clinical practice in the United States, including both community and academic treatment settings.

Study identification

NCT ID
NCT04919122
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Duke University
Other
Enrollment
468 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
19 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2022 (Actual)
Primary completion
Dec 31, 2026 (Estimated)
Completion
Dec 31, 2026 (Estimated)
Last update posted
Aug 5, 2026

2022 – 2026

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
State University of Iowa Iowa City Iowa 52242 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Ochsner Clinic Foundation d/b/a Ochsner Health New Orleans Louisiana 70121 —
The Johns Hopkins University Baltimore Maryland 21205 —
The Regents of the University of Michigan Ann Arbor Michigan 48109 —
Mayo Clinic Rochester Minnesota 55905 —
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Duke University Durham North Carolina 27710 —
The Ohio State University Columbus Ohio 43210 —
Geisinger Clinic Danville Pennsylvania 17822 —
University of Pittsburgh Pittsburgh Pennsylvania 15260 —
The University of Texas Southwestern Medical Center Dallas Texas 75390 —
University of Utah Salt Lake City Utah 84112 —
The Medical College of Wisconsin, Inc. Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04919122, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 5, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04919122 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →